Side-by-side comparison of AI visibility scores, market position, and capabilities
Illumio is a zero trust segmentation platform that maps application dependencies and enforces workload-level policy to contain breaches across cloud, data center, and endpoints.
Illumio is a cybersecurity company headquartered in Sunnyvale, California that pioneered the zero trust segmentation category — providing visibility into application communication flows and enforcing workload-level micro-segmentation policies across hybrid cloud, data center, and endpoint environments to limit the lateral movement that makes ransomware and supply chain attacks so damaging. Founded in 2013, Illumio raised $225 million in a 2021 Series F that valued the company at $2.75 billion, reflecting enterprise demand for segmentation technology as a breach containment control independent of network perimeter tools. The company's core thesis is that breaches are inevitable and that security programs must invest in preventing attackers who have entered the environment from moving freely to reach high-value targets.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.